OAC
IONS icon

OMERS Administration Corp’s Ionis Pharmaceuticals IONS Stock Holding History

OMERS Administration Corp’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-25,400
Closed -$2.14M – 432
2019
Q1 		$2.14M Buy
+25,400
New +$1.64M 0.02% 141
2016
Q3 		– Sell
-21,800
Closed -$508K – 624
2016
Q2 		$508K Buy
+21,800
New +$703K 0.01% 448

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OMERS Administration Corp's IONS Position: Q2 2019 in Review

OMERS Administration Corp sold out of Ionis Pharmaceuticals (IONS) in Q2 2019, closing a stake of 25,400 shares — an estimated $2.14M sold.

OMERS Administration Corp first reported a position in IONS in Q2 2016 and held it in 2 quarters. The position peaked at $2.14M in Q1 2019. 396 funds tracked by Wall St. Rank hold IONS as of Q2 2019.

  • OMERS Administration Corp reported no remaining Ionis Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • OMERS Administration Corp sold 25,400 Ionis Pharmaceuticals shares in Q2 2019, an estimated $2.14M.
  • OMERS Administration Corp first reported a position in Ionis Pharmaceuticals in Q2 2016 and held it in 2 quarters.
  • OMERS Administration Corp's Ionis Pharmaceuticals position peaked at $2.14M in Q1 2019.
  • 396 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2019.

Based on OMERS Administration Corp's 13F filing for Q2 2019, filed 8 Aug 2019.